ADAM9 as a Potential Target Molecule in Cancer
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2282-2287
Author(s):
Lucie Peduto
Targeting ADAM12 in Human Disease: Head, Body or Tail?
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2300-2310
Author(s):
J. Jacobsen and U. M. Wewer
The Therapeutic Potential of ADAM15
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2311-2318
Author(s):
Neali Lucas, Abdo J. Najy and Mark L. Day
Peptides Targeting Angiogenesis Related Growth Factor Receptors
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2414-2429
Author(s):
Luca D. D'Andrea, Annarita Del Gatto, Lucia De Rosa, Alessandra Romanelli and Carlo Pedone
Current Status and Perspectives in Peptide Receptor Radiation Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2453-2462
Author(s):
Catherine Ansquer, Francoise Kraeber-Bodere and Jean Francoise Chatal
Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Journal:
Current Drug Metabolism
Volume:
10
Page:
595-616
Author(s):
Snehasis Jana and Sandhya Mandlekar
Action Mechanisms of Chinese Herbal Compound at the Molecular Level
Journal:
Letters in Drug Design & Discovery
Volume:
6
Page:
397-402
Author(s):
Lu Yan, Yong-Min Lao and Jian-Guo Jiang
Radiolabelled Peptides: Eon in Radiopharmaceutical
Journal:
Current Radiopharmaceuticals
Volume:
2
Page:
199-213
Author(s):
Vikash Kumar, Permender Rathee, Kanchan Kohli, Hema Chaudhary and Sushila Rathee
Advances in α(v)β(3) Integrin-Targeting Cancer Therapy and Imaging with Radiolabeled RGD Peptides
Journal:
Current Radiopharmaceuticals
Volume:
2
Page:
214-219
Author(s):
Petar M. Mitrasinovic
The Rational Design of Anticancer Platinum Complexes: The Importance of the Structure-Activity Relationship
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
2235-2260
Author(s):
Angel M. Montana and Consuelo Batalla